Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Thyroid nodules are epidemic in certain countries. Advancements in imaging technology and increased healthcare screening have led to a notable rise in their detection. This surge in detection has also sparked a renewed focus on understanding their pathophysiology. Limited research exists regarding involvement of proinflammatory cytokines in thyroid disorders. We studied the presence of these proinflammatory cytokines in preoperative serum samples from the tissue of interest (colloid) retrieved during surgery, and postoperative serum samples.

Materials And Methods: We performed a prospective study including patients having solitary thyroid nodule (colloid goiter) undergoing surgery. A total of 3 mL each of preoperative serum sample, aspirated colloid from thyroid specimen, and postoperative serum sample 4 weeks after surgery were collected. The quantification of supernatant cytokines (IL-1, IL-4, IL-6, IL-10, IL-12, IL-17A, IFN-γ, TNF-α, and TGF-β) was done by ELISA. Standard protocols for ELISA were followed, and all assays were performed in duplicate to ensure accuracy.

Results: The study included 40 patients with a median age of 32.5 years (27-48.5 years). The majority of our participants were female, reflecting the higher prevalence of thyroid nodules in women. On analyzing the levels of proinflammatory cytokines, significant differences were seen between the preoperative serum sample, colloid sample, and postoperative serum sample. Colloid had considerably higher levels of proinflammatory cytokines (IL-1, IL-4, IL-6, IL-10, IL-12, IL-17A, IFN-γ, TNF-α, and TGF-β) when compared to both pre- and postoperative serum samples (p < 0.05).

Conclusion: Markedly elevated levels of proinflammatory cytokines seen in colloid obtained during surgery compared to both the pre- and postoperative serum samples suggest that the inflammatory milieu of thyroid tissue is different to that of the systemic circulation. These findings provide a foundation for further research into the inflammatory mechanisms.

Research Registry Registration: No: 8638 dated January 22, 2023.

Download full-text PDF

Source
http://dx.doi.org/10.1002/wjs.12643DOI Listing

Publication Analysis

Top Keywords

proinflammatory cytokines
20
postoperative serum
16
serum sample
16
thyroid nodules
12
preoperative serum
12
serum samples
8
cytokines il-1
8
il-1 il-4
8
il-4 il-6
8
il-6 il-10
8

Similar Publications

Microglia, the resident immune cells of the central nervous system (CNS), are involved in the pathogenesis of neurodegenerative diseases, such as Alzheimer's disease (AD), Dementia with Lewy Bodies (DLB), and Parkinson's disease (PD). 14-3-3 proteins act as molecular hubs to regulate protein-protein interactions, which are involved in numerous cellular functions, including cellular signaling, protein folding, and apoptosis. We previously revealed decreased 14-3-3 levels in the brains of human subjects with neurodegenerative diseases.

View Article and Find Full Text PDF

Repopulating Microglia Suppress Peripheral Immune Cell Infiltration to Promote Poststroke Recovery.

CNS Neurosci Ther

September 2025

Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.

Aims: Sustained neuroinflammation following ischemic stroke impedes post-injury tissue repairment and neurological functional recovery. Developing innovative therapeutic strategies that simultaneously suppress detrimental inflammatory cascades and facilitate neurorestorative processes is critical for improving long-term rehabilitation outcomes.

Methods: We employed a microglia depletion-repopulation paradigm by administering PLX5622 for 7 days post-ischemia; followed by a 7-day withdrawal period to allow microglia repopulation.

View Article and Find Full Text PDF

Background And Hypothesis: Schizophrenia is linked to hippocampal dysfunction and microglial inflammatory activation. Our prior clinical findings revealed significantly reduced transient receptor potential vanilloid 1 (TRPV1) expression in both first-episode and recurrent schizophrenia patients, with levels inversely correlating with symptom severity, implicating TRPV1 dysfunction in disease progression. Preclinical maternal separation (MS) models recapitulate schizophrenia-like behavioral and synaptic deficits, paralleled by hippocampal microglial TRPV1 downregulation.

View Article and Find Full Text PDF

A Transformable Nanoplatform Precisely Positions Fibroblast-Like Synoviocytes via FAP-α for Improved Rheumatoid Arthritis Therapy.

Adv Healthc Mater

September 2025

State Key Laboratory of Southwestern Chinese Medicine Resources, College of Modern Chinese Medicine Industry, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.

Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by joint inflammation, damage, and disability. Activated fibroblast-like synoviocytes (FLSs), abundant in RA synovium, crucially facilitate disease progression. These activated FLSs drive RA pathogenesis by upregulating adhesion molecules, proinflammatory cytokines, chemokines, and major histocompatibility complex class II (MHC-II).

View Article and Find Full Text PDF

Nature-inspired IL-1 targeted therapy to treat chronic inflammatory diseases.

Mol Ther

September 2025

Department of Medicine, UMass Chan Medical School, Worcester, MA, USA; Department of Genetic and Cellular Medicine, UMass Chan Medical School, Worcester, MA, USA; Horae Gene Therapy Center, UMass Chan Medical School, Worcester, MA, USA; Li Weibo Institute for Rare Diseases Research, UMass Chan Medic

The interleukin (IL)-1 pathway is a key mediator of inflammation and innate immune responses. Its dysregulation contributes to rheumatoid arthritis (RA) and autoinflammatory diseases (AIDs). In this study, we develop a recombinant adeno-associated virus (rAAV)-based gene therapy to deliver an inflammation-inducible, secreted human IL-1 receptor antagonist (sIL-1Ra) as a complementary approach to existing IL-1 blockers.

View Article and Find Full Text PDF